Skip to main content
    P

    ProMIS Neurosciences Inc. (PMN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.21
    -0.10 (-3.02%)

    Market Cap: $29.60M

    Last updated: Nov 17, 2026 at 4:23 PM ET

    ProMIS Neurosciences Inc. (PMN) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    ProMIS Neurosciences (PMN) has a latest price of $3.21 on Nov 17, 2026, 88.3% below its 52-week high of $27.40. Its price fell 67.0% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 54.6%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $44,820.54 in Jan 2018 and its lowest $3.31 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart PMN with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PMN.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 78.1%, and over 6 months it fell 69.9%. The month-end price fell 92.4% over the 3 years through Oct 2026, a compound annual decline of 57.7%.

    PeriodChange
    1 month-61.0%
    3 months-78.1%
    6 months-69.9%
    12 months-67.0%
    12 months, with dividends-67.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-92.4%-57.7%
    5 years-100.0%-81.0%
    10 years-100.0%-54.6%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 66.7%, and its weakest was 2022, when it fell 98.9%.

    YearCloseChange
    2026 through Oct 2026$3.31-51.5%
    2025$6.83-71.2%
    2024$23.70-17.6%
    2023$28.75-73.5%
    2022$108.50-98.9%
    2021$9,860.52+32.7%
    2020$7,431.25-36.2%
    2019$11,653.34-34.6%
    2018$17,829.61+17.0%
    2017$15,238.98+66.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 63.5% below its 50-day average of $8.80 and 74.3% below its 200-day average of $12.49.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$3.21
    52-week high$27.40-88.3%
    52-week low$2.78+15.5%
    50-day average$8.80-63.5%
    200-day average$12.49-74.3%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 95.7%.

    MeasureValue
    1-year beta1.99
    Largest fall, 1 year-87.9%
    Largest fall, 3 years-95.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About PMN

    What is PMN's 1-year price change?

    ProMIS Neurosciences's price fell 67.0% over the past 12 months. With dividends included, the 12-month total return was -67.0%.

    What is PMN's 5-year price change?

    ProMIS Neurosciences's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 81.0%. These figures leave out dividends.

    What is PMN's 52-week high and low?

    ProMIS Neurosciences's 52-week high is $27.40 and its 52-week low is $2.78. Its latest price of $3.21 on Nov 17, 2026 is 88.3% below the high.

    What is PMN's beta?

    ProMIS Neurosciences's 1-year beta against the S&P 500 is 1.99, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 87.9%.

    Is the PMN chart free?

    Yes. Advanced Charting for PMN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.